Recently, 18-Fluoride labeled sodium fluoride positron emission tomography (18F-NaF PET) has been introduced as a new modality aimed at detecting bone metastatic lesions. Bone imaging with NaF PET provides high… Click to show full abstract
Recently, 18-Fluoride labeled sodium fluoride positron emission tomography (18F-NaF PET) has been introduced as a new modality aimed at detecting bone metastatic lesions. Bone imaging with NaF PET provides high sensitivity and high resolution compared to bone scintigraphy using 99mTc-methylene diphosphonate (99mTc-MDP). We report a case where NaF PET was useful for evaluating bone metastasis with castration-resistant prostate cancer (CRPC) after treatment with Radium 223 (Ra-223).
               
Click one of the above tabs to view related content.